1. Activist Investor Sarissa Targets Three Innoviva Board Seats

    Activist Investor Sarissa Targets Three Innoviva Board Seats

    Activist investor Sarissa Capital Management LP said on Monday it intends to nominate only three candidates for election to the board of drug company Innoviva Inc ( INVA.O ). Innoviva said last week that Sarissa Capital had nominated four directors to replace a majority of the drug company's board. Sarissa Capital is a hedge fund run by Alex Denner, billionaire investor Carl Icahn's former healthcare lieutenant. The fund has a stake of 2.72 percent in Innoviva, according to Reuters data...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We expect our nominees, if elected, will work to instill in Innoviva much needed financial discipline and oversight.
  3. Topics Mentioned

  4. Authors